We could not find any results for:
Make sure your spelling is correct or try broadening your search.
ANN ARBOR, MI -- (Marketwire) -- 10/06/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI -- (Marketwire) -- 09/19/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI -- (Marketwire) -- 08/19/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI -- (Marketwire) -- 08/19/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI -- (Marketwire) -- 08/14/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI -- (Marketwire) -- 08/12/08 -- Pipex Pharmaceuticals, Inc. (AMEX: PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
ANN ARBOR, MI , a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, today announced results and...
ANN ARBOR, MI , a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous systems and autoimmune diseases, today announced that it...
ANN ARBOR, MI , a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of central nervous system and autoimmune diseases, announced today that...
ANN ARBOR, MI , a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and autoimmune diseases, announced it was issued a United States...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.05 | -0.194931773879 | 25.65 | 26.13 | 25.1601 | 6058 | 25.57412722 | SP |
4 | -2.6 | -9.21985815603 | 28.2 | 28.4 | 25.1601 | 8063 | 26.34042012 | SP |
12 | -2.14 | -7.71449170872 | 27.74 | 29.02 | 25.1601 | 10783 | 26.81844825 | SP |
26 | -5.35 | -17.2859450727 | 30.95 | 32.0199 | 25.1601 | 14048 | 28.37318894 | SP |
52 | 0.87 | 3.51799433886 | 24.73 | 32.0199 | 23.79 | 15812 | 27.458195 | SP |
156 | 5.62 | 28.1281281281 | 19.98 | 32.0199 | 16.57 | 22514 | 24.38847156 | SP |
260 | 5.62 | 28.1281281281 | 19.98 | 32.0199 | 16.57 | 22514 | 24.38847156 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions